Compare Fulford India with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs ALKEM LABORATORIES - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA ALKEM LABORATORIES FULFORD INDIA/
ALKEM LABORATORIES
 
P/E (TTM) x 398.8 - - View Chart
P/BV x 6.2 6.9 90.3% View Chart
Dividend Yield % 0.1 0.6 13.4%  

Financials

 FULFORD INDIA   ALKEM LABORATORIES
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
ALKEM LABORATORIES
Mar-16
FULFORD INDIA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs9421,589 59.3%   
Low Rs4501,232 36.5%   
Sales per share (Unadj.) Rs691.4417.5 165.6%  
Earnings per share (Unadj.) Rs11.556.3 20.4%  
Cash flow per share (Unadj.) Rs15.464.7 23.7%  
Dividends per share (Unadj.) Rs2.0012.70 15.7%  
Dividend yield (eoy) %0.30.9 31.9%  
Book value per share (Unadj.) Rs380.0292.9 129.7%  
Shares outstanding (eoy) m3.90119.57 3.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.4 29.8%   
Avg P/E ratio x60.725.1 242.4%  
P/CF ratio (eoy) x45.321.8 207.9%  
Price / Book Value ratio x1.84.8 38.0%  
Dividend payout %17.422.6 77.3%   
Avg Mkt Cap Rs m2,714168,653 1.6%   
No. of employees `0000.4NA-   
Total wages/salary Rs m5059,171 5.5%   
Avg. sales/employee Rs Th6,073.0NM-  
Avg. wages/employee Rs Th1,137.4NM-  
Avg. net profit/employee Rs Th100.7NM-  
INCOME DATA
Net Sales Rs m2,69649,915 5.4%  
Other income Rs m1251,645 7.6%   
Total revenues Rs m2,82251,561 5.5%   
Gross profit Rs m-468,482 -0.5%  
Depreciation Rs m151,006 1.5%   
Interest Rs m10671 1.4%   
Profit before tax Rs m548,451 0.6%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m101,606 0.6%   
Profit after tax Rs m456,731 0.7%  
Gross profit margin %-1.717.0 -10.1%  
Effective tax rate %17.719.0 93.0%   
Net profit margin %1.713.5 12.3%  
BALANCE SHEET DATA
Current assets Rs m1,73827,062 6.4%   
Current liabilities Rs m54515,324 3.6%   
Net working cap to sales %44.323.5 188.2%  
Current ratio x3.21.8 180.7%  
Inventory Days Days4867 72.9%  
Debtors Days Days441 10.4%  
Net fixed assets Rs m1212,610 0.1%   
Share capital Rs m39239 16.3%   
"Free" reserves Rs m1,44334,490 4.2%   
Net worth Rs m1,48235,027 4.2%   
Long term debt Rs m01,212 0.0%   
Total assets Rs m2,07754,387 3.8%  
Interest coverage x6.713.6 49.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.9 141.5%   
Return on assets %2.613.6 19.2%  
Return on equity %3.019.2 15.7%  
Return on capital %4.324.9 17.3%  
Exports to sales %012.9 0.0%   
Imports to sales %24.53.1 792.3%   
Exports (fob) Rs mNA6,461 0.0%   
Imports (cif) Rs m6591,540 42.8%   
Fx inflow Rs m176,563 0.3%   
Fx outflow Rs m6733,012 22.4%   
Net fx Rs m-6563,552 -18.5%   
CASH FLOW
From Operations Rs m907,259 1.2%  
From Investments Rs m1051,864 5.6%  
From Financial Activity Rs m-14-9,273 0.2%  
Net Cashflow Rs m181-150 -120.3%  

Share Holding

Indian Promoters % 0.0 66.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 33.1 11.5%  
FIIs % 0.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 0.0 -  
Shareholders   4,783 68,381 7.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   BIOCON   CADILA HEALTHCARE  VENUS REMEDIES  PANACEA BIOTECH  GLENMARK PHARMA  

Compare FULFORD INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 170 Points Higher; IT and Banking Stocks Witness Buying(Closing)

Indian share markets traded on a volatile note throughout the day and ended higher. Benchmark Indices were highly volatile swinging between positive and negative territory.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 5-YR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS